Pleomorphic rhabdomyosarcoma showing smooth-muscle and fibrohistiocytic differentiation: A single case report

Ultrastructural Pathology

Volumn 34, Issue 1, 2010, Pages 42-47

  Eyden, Brian ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Fibrohistiocytic differentiation; Pleomorphic sarcoma; Rhabdomyosarcoma; Smooth muscle differentiation; Ultrastructure

Indexed keywords

ACTIN; ALPHA SMA PROTEIN, HUMAN; ALPHA-SMA PROTEIN, HUMAN; TUMOR MARKER;

ADJUVANT THERAPY; AGED; ARTICLE; CASE REPORT; CELL TRANSFORMATION; DISEASE FREE SURVIVAL; FIBROBLAST; HISTIOCYTE; HUMAN; LYSOSOME; MALE; METABOLISM; PATHOLOGY; RHABDOMYOSARCOMA; ROUGH ENDOPLASMIC RETICULUM; SMOOTH MUSCLE; SOFT TISSUE TUMOR; TREATMENT OUTCOME; ULTRASTRUCTURE;

ACTINS; AGED; CELL TRANSFORMATION, NEOPLASTIC; DISEASE-FREE SURVIVAL; ENDOPLASMIC RETICULUM, ROUGH; FIBROBLASTS; HISTIOCYTES; HUMANS; LYSOSOMES; MALE; MUSCLE, SMOOTH; RADIOTHERAPY, ADJUVANT; RHABDOMYOSARCOMA; SOFT TISSUE NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 75149191040     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913120903353795     Document Type: Article

References (36)

1. Fletcher CDM, Unni K, Mertens F. World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002:146-154.
2. Palmer NF, Foulkes M. Histopathology and prognosis in the second Intergroup Rhabdomyosarcoma Study (IRS II). Proc Am Soc Clin Oncol. 1987;3:897.
3. Cavazzana AO, Schmidt D, Ninfo V, et al. Spindle cell rhabdomyosarcoma: a prognostically favourable variant of rhabdomyosarcoma. Am J Surg Pathol. 1992;16:229-235.
4. Tsokos M, Webber B, Parham D, et al. Rhabdomyosarcoma: a new classification scheme related to prognosis. Arch Pathol Lab Med. 1992;116:847-855.
5. Edel G, Wuisman P, Erlemann R. Spindle cell (leiomyomatous) rhabdomyosarcoma, a rare variant of embryonal rhabdomyosarcoma. Pathol Res Pract. 1993;189:102-107.
6. Leuschner I, Newton WA, Schmidt D, et al. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region: a report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol. 1993;17:221-230.
7. Leuschner I. Spindle cell rhabdomyosarcoma: histologic variant of embryonal rhabdomyosarcoma with association to favorable prognosis. Curr Top Pathol. 1995;89:261-272.
8. Don DM, Newman AN, Fu YS. Spindle cell variant of embryonal rhabdomyosarcoma. Otolaryngol Head Neck Surg. 1997;116:529-532.
9. Qualman SJ, Coffin CM, Newton WA, et al. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol. 1998;1:550-561.
10. Rubin BP, Hasserjian RP, Singer S, et al. Spindle cell rhabdomyosarcoma (so-called) in adults: report of two cases with emphasis on differential diagnosis. Am J Surg Pathol. 1998;22:459-464.
11. Gil-Benso R, Carda-Batalla C, Navarro-Fos S, et al. Cytogenetic study of a spindle-cell rhabdomyosarcoma of the parotid gland. Cancer Genet Cytogenet. 1999;109:150-153.
12. Val-Bernal JF, Fernández N, Gómez-Roman JJ. Spindle cell rhabdomyosarcoma in adults: a case report and literature review. Pathol Res Pract. 2000;196:67-72.
13. Kizer WS, Dykes TE, Brent EL, et al. Paratesticular spindle cell rhabdomyosarcoma in an adult. J Urol. 2001;166:606-607.
14. Debiec-Rychter M, Hagemeijer A, Sciot R. Spindle cell rhabdomyosarcoma with 2q36,q37 involvement. Cancer Genet Cytogenet. 2003;140:62-65.
15. Gupta A, Maddolozzo J, Win Htin T, et al. Spindle cell rhabdomyosarcoma of the tongue in an infant: a case report with emphasis on differential diagnosis of childhood spindle cell lesions. Pathol Res Pract. 2004;200:537-543.
16. Daneshbod Y, Monabati A, Kumar PV, Rastegar M. Paratesticular spindle cell rhabdomyosarcoma diagnosed by fine needle aspiration cytology: a case report. Acta Cytol. 2005;49:331-334. (Pubitemid 40677536)
17. Nascimento AF, Fletcher CDM. Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol. 2005;29:1106-1113.
18. Diniz G, Aktas S, Ortac R, et al. Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy. Pathol Res Pract. 2006;202:671-677.
19. Mentzel T, Kühnen C. Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases. Virchows Arch. 2006;449:554-560.
20. Silvestris N, Zito FA, Resta L, et al. Unique case of giant adult paratesticular spindle cell rhabdomyosarcoma. Urology. 2009;73:500-502.
21. Bahrami A, Gown AM, Baird GS, et al. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. Mod Pathol. 2008;21:795-806.
22. Houreih MA, Lin AY, Eyden B, et al. Alveolar rhabdomyosarcoma with neuroendocrine differentiation-report of 3 cases. Int J Surg Pathol. 2009;17:135-141.
23. Mentzel T, Katenkamp D. Sclerosing, pseudovascular rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of three cases. Virchows Arch. 2000;436:305-311.
24. FolpeAL, McKenney JK, Bridge JA, Weiss SW. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol. 2002;26:1175-1183.
25. Chiles MC, Parham DM, Qualman SJ, et al. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study group and Children's Oncology group. Pediatr Dev Pathol. 2004;7:583-594.
26. Croes R, Debiec-Rychter M, Cokelaere K, et al. Adult sclerosing rhabdomyosarcoma: cytogenetic link with embryonal rhabdomyosarcoma. Virchows Arch. 2005;446:64-67.
27. Knipe TA, Chandra RK, Bugg MF. Sclerosing rhabdomyosarcoma: a rare variant with predilection for the head and neck. Laryngoscope. 2005;115:48-50.
28. Zuppan C, Mierau GW, Weeks DA. Lipid-rich rhabdomyosarcoma- a potential source of diagnostic confusion. Ultrastruct Pathol. 1991;15:353-359.
29. Bégin LR, Schü rch W, Lacoste J, et al. Glycogen-rich clear cell rhabdomyosarcoma of the mediastinum: potential diagnostic pitfall. Am J Surg Pathol. 1994;18:302-308.
30. Quincey C, Banerjee SS, Eyden BP, Vasudev KS. Lipid rich rhabdomyosarcoma. J Clin Pathol. 1994;47:280-282.
31. Boman F, Schmitt C, Beurey P, et al. Clear cell rhabdomyosarcoma. Pediatr Pathol Lab Med. 1996;16:951-959.
32. Schü rch W, Bégin LR, Seemayer TA, et al. Pleomorphic soft tissue myogenic sarcomas of adulthood: a reappraisal in the mid-1990s. Am J Surg Pathol. 1996;20:131-147.
33. Gaffney EF, Dervan PA, Fletcher CDM. Pleomorphic rhabdomyosarcoma in adulthood: analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol. 1993;17:601-609.
34. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol. 2001;14:595-603.
35. LaValle Bundtzen J, Norback DH. The ultrastructure of poorly differentiated rhabdomyosarcomas: a case report and literature review. Hum Pathol. 1982;13:301-313.
36. Li Y, Foster W, Deasy BM, et al. Transforming growth factor b-1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol. 2004;164:1007-1019.